Grüneberg and Myers PLLC Launches New International Patent Firm
TYSONS, Va. (September 20, 2017) — Dr. Kirsten Grüneberg and Eric Myers are pleased to announce the launch of a new international patent firm, Grüneberg and Myers PLLC. The attorneys both formerly practiced at Oblon, McClelland, Maier & Neustadt LLP, where Grüneberg was head of European Practice. They are forming the firm with a former Oblon colleague, Dr. Richard Chinn, a chemical patent attorney. Recognizing the market need for more personalized and efficient representation, Grüneberg and Myers PLLC officially opened on September 20, 2017 to provide strategic patent counseling to longtime clients ranging from multinational corporations, startup companies, and academic institutions.
Noteworthy among law firms, Grüneberg and Myers is 100 percent female- and minority-owned. “We plan to take a diversity-minded approach to attract the best talent in patent law,” noted Grüneberg. “Our differences and diverse perspectives make us stronger.”
The Grüneberg and Myers firm presents a team with extensive experience in representing European and U.S. clients in chemical, materials science, life science and pharmaceutical fields. The team also has notable experience in counseling and representing companies from Japan. Collectively, they bring decades of combined background in patent prosecution, counseling, freedom-to-operate opinions, and M&A due diligence.
Grüneberg, who has been named by Intellectual Asset Management (IAM) as one of the nation’s top patent practitioners, counsels many of the world’s largest chemical, biotech and pharmaceutical companies and helps them to address their intellectual property and business needs. Myers works with clients on a wide variety of patent issues including patentability, invalidity, non-infringement, design-around strategies, and challenging patent validity after issuance. Chinn offers a wide range of experience in client counseling, patent prosecution, application preparation, patentability and infringement evaluation and litigation in chemical technologies.
The introduction of the America Invents Act (AIA) in 2011 transformed U.S. patent law and ushered in a wave of uncertainty. The Inter Partes Review and Post-Grant Review trial proceedings have had an inescapable impact on the value of patent prosecution and litigation. Now, the Supreme Court’s grant of a writ of certiorari in the Oil States case threatens the constitutionality of the AIA trial proceedings altogether, further contributing to uncertainty in the field.
“Grüneberg and Myers is able to weather these industry changes by providing high-quality service through a low-overhead framework, and we have strategically designed our firm with a keen eye on every dollar to ensure that we remain agile and lean,” explained Myers. “Minimized overhead will free us up to treat every case with individualized care. We won’t need to churn through volume quickly just to stay profitable.”
Legal consulting firm Altman Weil reports that while more than 90 percent of managing partners at top law firms see improved practice efficiency as a permanent trend in the future, less than half have changed their approach accordingly. In this respect, Grüneberg and Myers is different.
“More and more, we see clients adopting new technologies and workflows. Our model will provide the flexibility to support these efforts and grow with clients into the future, whatever it may bring,” noted Grüneberg.
Launched in September 2017, Grüneberg and Myers PLLC is a 100 percent female- and minority-owned international patent firm. With a broad and sophisticated practice, the firm provides a full range of patent support services, including patent prosecution, counseling, post-grant representation, and M&A due diligence to meet the growing and diverse needs of U.S.-based, European, and Asian companies, entrepreneurs, and inventors.